Compare FUNC & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FUNC | TKNO |
|---|---|---|
| Founded | 1900 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.8M | 138.1M |
| IPO Year | 2012 | 2021 |
| Metric | FUNC | TKNO |
|---|---|---|
| Price | $35.86 | $2.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.0K | ★ 156.7K |
| Earning Date | 05-06-2026 | 06-03-2026 |
| Dividend Yield | ★ 2.88% | N/A |
| EPS Growth | 19.68 | ★ 43.86 |
| EPS | ★ 3.77 | N/A |
| Revenue | $18,426,000.00 | ★ $40,520,000.00 |
| Revenue This Year | $13.05 | $8.65 |
| Revenue Next Year | $6.56 | $13.16 |
| P/E Ratio | $9.58 | ★ N/A |
| Revenue Growth | 4.01 | ★ 7.35 |
| 52 Week Low | $24.80 | $1.91 |
| 52 Week High | $41.95 | $7.48 |
| Indicator | FUNC | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 43.22 | 60.65 |
| Support Level | $35.93 | N/A |
| Resistance Level | $36.70 | $5.39 |
| Average True Range (ATR) | 0.80 | 0.21 |
| MACD | 0.06 | 0.11 |
| Stochastic Oscillator | 38.26 | 90.70 |
First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.